Cohort Company News - MedTech Innovator

BARDA partners with Aidar Health, Inc. to develop and validate machine learning algorithm for rapid health assessment and patient triage

DateSep 27 2021

BARDA is collaborating with Aidar Health, Inc. to develop and validate the company’s Aidar COVID-19 decompensation index (AIDI), a new early warning system that uses...

Respira wins NIH grant

DateSep 25 2021

Today, we were notified that Respira Labs was chosen out of 103 applicants in the US (three winners, only female and Latino led) to be awarded The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep Diseases.

Is India geared up for regular screening of CHDs in kids?

DateSep 25 2021

HD Medical has developed the HD Steth, cleared by the US FDA, that addresses this problem.

Is India geared up for regular screening of CHDs in kids? (featuring HD Medical)

DateSep 25 2021

HD Medical has developed the HD Steth, cleared by the US FDA, that addresses this problem. Chennai: Congenital Heart Defects (CHDs) are among the most...

21 start-ups selected to innovate for healthy ageing, feat. SepTec

DateSep 22 2021

The awards are part of the Healthy Longevity Global Competition – a multiyear, multimillion-dollar international competition seeking breakthrough innovations to extend human health and function later in life.

Xealth Secures $24 Million in Series B Funding to Accelerate Digital Health

DateSep 21 2021

Xealth, the leader in enabling digital health at scale, today announced that the company has secured $24 million in Series B funding led by Advocate Aurora Enterprises, a subsidiary of Advocate Aurora Health.

Co-founder of Avisi Technologies named one of the Greater Philadelphia’s Inno Under 25

DateSep 21 2021

Along with co-founder Brandon Kao, Rui Jing Jiang started Avisi Technologies in 2017, developing VisiPlate, a nanotechnology-enabled ocular implant to treat glaucoma.

Co-founder of Avisi Technologies named one of the Greater Philadelphia’s Inno Under 25

DateSep 21 2021

Applaud Medical wins FDA breakthrough device designation for urinary stone deviceAlong with co-founder Brandon Kao, Rui Jing Jiang started Avisi Technologies in 2017, developing VisiPlate,...

Naluri: The Digital Health Tech Company Of The Future

DateSep 21 2021

Digital health tech company Naluri gives you remote digital health monitoring and expert advice in the palm of your hands. When it comes to the...

Bluegrass Vascular Announces Decision by Medicare to Assign a New Technology Ambulatory Payment Classification (APC) for the Surfacer® System Procedure

DateSep 20 2021

The new code is C9780, Insertion of central venous catheter through central venous occlusion via inferior and superior approaches (e.g., inside-out technique), including imaging guidance.

Rhaeos, Inc. Awarded $4 Million NIH SBIR Grant to Expand Quantitative Measurement Capabilities of its FlowSense™ Noninvasive Wireless Sensor

DateSep 16 2021

Rhaeos, Inc., a private medical device company focused on the care of patients with hydrocephalus, announced today it was awarded a $4 million, multi-year grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program through the National Institute of Neurological Disorders and Stroke (NINDS).

FDA Clears Fully Automated Cardiac Ultrasound Solution to Measure 2D and Doppler

DateSep 14 2021

Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S. Food and Drug Administration (FDA) clearance for Us2.v1, a completely automated decision support tool for echocardiography.

Vertigo Treatment Receives FDA Breakthrough Device Designation, featuring Otolith Labs

DateSep 13 2021

Otolith Labs, launched at the Halcyon Incubator, has received U.S. Food and Drug Administration (FDA) Breakthrough Device designation for its medical device that is designed to be prescribed by physicians for the treatment of vertigo.

Automated lung sound analysis using the LungPass platform: a sensitive and specific tool for identifying lower respiratory tract involvement in COVID-19

DateSep 09 2021

Lower respiratory tract (LRT) involvement, observed in about 20% of patients suffering from coronavirus disease 2019 (COVID-19), is associated with a more severe clinical course, adverse outcomes, and long-term sequelae [1, 2].

Madorra wins FDA breakthrough nod for home vulvovaginal atrophy treatment device

DateSep 09 2021

Madorra this week said it has received FDA breakthrough device designation for its noninvasive, home-use device for moderate to severe vulvovaginal atrophy.

Nutromics won in the category of ‘Technology Platform Solution of the Year’ at the AIIA’s 2021 national iAwards!

DateSep 09 2021

We are excited to announce that last night Nutromics won in the category of 'Technology Platform Solution of the Year' at the AIIA's 2021 national iAwards!

InBrace Raises $102M Series D Financing

DateSep 08 2021

InBrace, the orthodontic company behind the novel Smartwire™ category of behind-the-teeth, teeth straightening, today announced the closing of an oversubscribed $102 million Series D financing by funds affiliated with new investor groups co-led by Farallon Capital Management, L.L.C. and Marshall Wace.

Stryker Acquires Med Device Company Gauss Surgical

DateSep 07 2021

Stryker today announced the acquisition of Gauss Surgical, a Menlo Park, CA-based medical device company that has developed Triton™, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery.

Sentien Biotechnologies Partners with BARDA to Evaluate High Dose Cohort in Phase 1/2 Trial of SBI-101 for Treatment of Acute Kidney Injury Associated with Sepsis

DateSep 02 2021

Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, today announced a partnership with the Biomedical Advanced Research and Development Authority (BARDA).

Onkos Surgical raises $15M Series C

DateSep 01 2021

Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopedic procedures based in Parsippany, announced Wednesday that it has raised $15 million in Series C funding from its existing investor syndicate.